486 related articles for article (PubMed ID: 30205580)
1. The Effects of Berberine on the Gut Microbiota in Apc
Wang H; Guan L; Li J; Lai M; Wen X
Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580
[No Abstract] [Full Text] [Related]
2. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.
Chen H; Ye C; Wu C; Zhang J; Xu L; Wang X; Xu C; Zhang J; Guo Y; Yao Q
Int J Biol Sci; 2023; 19(7):2097-2113. PubMed ID: 37151876
[TBL] [Abstract][Full Text] [Related]
3. Anti-obesity and Gut Microbiota Modulation Effect of Astragalus Polysaccharides Combined with Berberine on High-Fat Diet-Fed Obese Mice.
Yue SJ; Wang WX; Zhang L; Liu J; Feng WW; Gao H; Tang YP; Yan D
Chin J Integr Med; 2023 Jul; 29(7):617-625. PubMed ID: 34921647
[TBL] [Abstract][Full Text] [Related]
4. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice.
Shi Y; Hu J; Geng J; Hu T; Wang B; Yan W; Jiang Y; Li J; Liu S
Biomed Pharmacother; 2018 Nov; 107():1556-1563. PubMed ID: 30257374
[TBL] [Abstract][Full Text] [Related]
5. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
Front Immunol; 2020; 11():588079. PubMed ID: 33072135
[TBL] [Abstract][Full Text] [Related]
6. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe
Zhu L; Zhang D; Zhu H; Zhu J; Weng S; Dong L; Liu T; Hu Y; Shen X
Atherosclerosis; 2018 Jan; 268():117-126. PubMed ID: 29202334
[TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
[TBL] [Abstract][Full Text] [Related]
8. Berberine alters gut microbial function through modulation of bile acids.
Wolf PG; Devendran S; Doden HL; Ly LK; Moore T; Takei H; Nittono H; Murai T; Kurosawa T; Chlipala GE; Green SJ; Kakiyama G; Kashyap P; McCracken VJ; Gaskins HR; Gillevet PM; Ridlon JM
BMC Microbiol; 2021 Jan; 21(1):24. PubMed ID: 33430766
[TBL] [Abstract][Full Text] [Related]
9. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids.
Yue SJ; Liu J; Wang AT; Meng XT; Yang ZR; Peng C; Guan HS; Wang CY; Yan D
Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E73-E85. PubMed ID: 30422704
[TBL] [Abstract][Full Text] [Related]
10. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism.
Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD
Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947
[TBL] [Abstract][Full Text] [Related]
11. Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects.
Zhao R; Coker OO; Wu J; Zhou Y; Zhao L; Nakatsu G; Bian X; Wei H; Chan AWH; Sung JJY; Chan FKL; El-Omar E; Yu J
Gastroenterology; 2020 Sep; 159(3):969-983.e4. PubMed ID: 32387495
[TBL] [Abstract][Full Text] [Related]
12. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
13. N-Acetylcysteine alleviates gut dysbiosis and glucose metabolic disorder in high-fat diet-fed mice.
Zheng J; Yuan X; Zhang C; Jia P; Jiao S; Zhao X; Yin H; Du Y; Liu H
J Diabetes; 2019 Jan; 11(1):32-45. PubMed ID: 29845722
[TBL] [Abstract][Full Text] [Related]
14. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
Yao Y; Chen H; Yan L; Wang W; Wang D
Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
[TBL] [Abstract][Full Text] [Related]
15. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.
Sun T; Liu S; Zhou Y; Yao Z; Zhang D; Cao S; Wei Z; Tan B; Li Y; Lian Z; Wang S
Oncotarget; 2017 Jan; 8(1):444-457. PubMed ID: 27880935
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.
Wang Y; Tong Q; Shou JW; Zhao ZX; Li XY; Zhang XF; Ma SR; He CY; Lin Y; Wen BY; Guo F; Fu J; Jiang JD
Theranostics; 2017; 7(9):2443-2451. PubMed ID: 28744326
[TBL] [Abstract][Full Text] [Related]
17. The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression.
Yang YN; Wang QC; Xu W; Yu J; Zhang H; Wu C
Biomed Pharmacother; 2022 Nov; 155():113749. PubMed ID: 36174380
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.
Kang C; Wang B; Kaliannan K; Wang X; Lang H; Hui S; Huang L; Zhang Y; Zhou M; Chen M; Mi M
mBio; 2017 May; 8(3):. PubMed ID: 28536285
[TBL] [Abstract][Full Text] [Related]
19. High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites.
Yang J; Wei H; Zhou Y; Szeto CH; Li C; Lin Y; Coker OO; Lau HCH; Chan AWH; Sung JJY; Yu J
Gastroenterology; 2022 Jan; 162(1):135-149.e2. PubMed ID: 34461052
[TBL] [Abstract][Full Text] [Related]
20. Effect of atorvastatin on the gut microbiota of high fat diet-induced hypercholesterolemic rats.
Khan TJ; Ahmed YM; Zamzami MA; Mohamed SA; Khan I; Baothman OAS; Mehanna MG; Yasir M
Sci Rep; 2018 Jan; 8(1):662. PubMed ID: 29330433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
